126 related articles for article (PubMed ID: 38831158)
1. Reporting Compliance and Factors Influencing Timeliness of Stroke-Related Trial Results on ClinicalTrials.gov.
Cwajna M; Hamouda AM; Kendall N; Ghozy S; Elder BD; Kallmes DF
Transl Stroke Res; 2024 Jun; ():. PubMed ID: 38831158
[TBL] [Abstract][Full Text] [Related]
2. Compliance with results reporting at ClinicalTrials.gov.
Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
[TBL] [Abstract][Full Text] [Related]
3. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML
Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787
[TBL] [Abstract][Full Text] [Related]
5. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
Prayle AP; Hurley MN; Smyth AR
BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
[TBL] [Abstract][Full Text] [Related]
7. Outcome reporting among drug trials registered in ClinicalTrials.gov.
Bourgeois FT; Murthy S; Mandl KD
Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
[TBL] [Abstract][Full Text] [Related]
9. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
[TBL] [Abstract][Full Text] [Related]
12. Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years.
Pellat A; Boutron I; Ravaud P
Oncologist; 2022 Nov; 27(11):e849-e855. PubMed ID: 35983949
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
Miller JE; Korn D; Ross JS
BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
[TBL] [Abstract][Full Text] [Related]
14. Overcoming non-compliance with clinical trial registration and results reporting: One Institution's approach.
Snider SH; Flume PA; Gentilin SL; Lesch WA; Sampson RR; Sonne SC
Contemp Clin Trials Commun; 2020 Jun; 18():100557. PubMed ID: 32258818
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
[TBL] [Abstract][Full Text] [Related]
16. Trial registration and results disclosure: impact of US legislation on sponsors, investigators, and medical journal editors.
Hirsch L
Curr Med Res Opin; 2008 Jun; 24(6):1683-9. PubMed ID: 18462565
[TBL] [Abstract][Full Text] [Related]
17. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of clinical trials associated with early results reporting at ClinicalTrials.gov.
Bashir R; Dunn AG
Contemp Clin Trials; 2022 Jun; 117():106785. PubMed ID: 35526836
[TBL] [Abstract][Full Text] [Related]
19. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA.
Talebi R; Redberg RF; Ross JS
Trials; 2020 Jul; 21(1):675. PubMed ID: 32703252
[TBL] [Abstract][Full Text] [Related]
20. Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis.
Rayi A; Thompson S; Gloss D; Malhotra K
Epilepsy Res; 2018 Jul; 143():1-6. PubMed ID: 29625272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
